About Index Trending news
Analyze
Pricing
ZIOPHARM Oncology

ZIOPHARM Oncology

Work at ZIOPHARM Oncology? Add yourself to this profile

ZIOPHARM Oncology

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
$120,000,000
Post-IPO equity
$57,500,000
Employees

Unknown size

Locations
HQ
Xconomy

Ziopharm Discloses Patient Death in Brain Cancer Trial, Shares Fall

Health
The Motley Fool

Better Buy: Ziopharm Oncology, Inc. vs. Celgene

The Motley Fool

Here's How Ziopharm Oncology Hopes to Win the CAR-T Race

The Motley Fool

Why Ziopharm Oncology Soared 49% In February

The Motley Fool

Why ZIOPHARM Oncology Inc. Published a Higher Stock Price Today